Chembio diagnostics announces election of leslie teso-lichtman to its board of directors

Hauppauge, n.y., may 24, 2022 (globe newswire) -- chembio diagnostics, inc. (chembio) (nasdaq: cemi), a leading point-of-care diagnostic company focused on infectious diseases, today announced the election of leslie teso-lichtman to its board of directors at chembio's 2022 annual meeting of stockholders.
CEMI Ratings Summary
CEMI Quant Ranking